Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_assertion type Assertion NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_head.
- NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_assertion description "[In tissue microrarray studies we now show that expression of high levels of nuclear E2F3 occurs in a high proportion (98/147, 67%) of human prostate cancers, but is a rare event in non-neoplastic prostatic epithelium suggesting a role for E2F3 overexpression in prostate carcinogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_provenance.
- NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_assertion evidence source_evidence_literature NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_provenance.
- NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_assertion SIO_000772 15184867 NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_provenance.
- NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_assertion wasDerivedFrom befree-20150227 NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_provenance.
- NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_assertion wasGeneratedBy ECO_0000203 NP363574.RAFAxbtP_CQHfPnp9-RSz5ZnIQXyc21Fr8G4mEhv6Br90130_provenance.